Molecular Genetic Approaches to the Neuropharmacology of Corticotropin-Releasing Factor
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
This article describes the integration of neurobiological and molecular genetic approaches in the study of the function of the neuropeptide corticotropin-releasing factor (CRF). CRF is a particularly relevant subject for targeted genetic mutation because of its hypothesized critical role in hormonal and behavioral responses to stressors, its potential role in psychopathology, and the limited neuropharmacological agents available to increase or decrease function in this system. We review the strategy of targeted genetic mutation in neuropharmacology using research directed at understanding the function of CRF and related neuropeptides through molecular genetic manipulation of the levels of the endogenous agonist, its different receptors, and the binding protein. Genetically engineered approaches to functional analysis cross-validate experiments to promote the neurobiological elucidation of complex systems and provide critical information about constituent differences that contribute to individual differences in brain function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925 · cited 1×
“A third urocortin-like peptide, urocortin III, also was characterized in mouse and human and also is a 38 amino acid peptide (Lewis et al., 2001).”
BackgroundSmith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892
Self-citationReyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887 · cited 1×
“Human urocortin II shares a 76% amino acid identity with mUcnII and is proposed to be the human analog of mUcnII (Reyes et al., 2001).”
BackgroundRadulovic, J., Rühmann, A., Liepold, T., & Spiess, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05016.1999 · Cited by 402 · cited 1×
“Recent studies have shown that the CRF-induced facilitation of memory may be mediated by CRF1 receptors (Radulovic et al., 1999).”
BackgroundCorticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide
Swerdlow, N. R., Geyer, M. A., Vale, W. W., & Koob, G. F. (1986) · Psychopharmacology · doi:10.1007/bf00652231 · Cited by 299
Self-citationHeinrichs, S. C., Menzaghi, F., Pich, E. M., Baldwin, H. A., Rassnick, S., Britton, K. T., & Koob, G. F. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380104 · Cited by 143 · cited 1×
“…antagonists are very effective in reversing the decrease in exploration of the open arms of an elevated plus-maze caused by exposure to a variety of stressors including restraint stress, swim stress, ethanol withdrawal and social stress (Heinrichs et al., 1992, 1994; Menzaghi et al., 1994).”
BackgroundSelf-citationMuglia, L. J., Jacobson, L., Weninger, S. C., Luedke, C. E., Bae, D. S., Jeong, K. H., & Majzoub, J. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119487 · Cited by 115 · cited 3×
“Heterozygote breeding was used to generate homozygous CRF-deficient (CRF knockout) mice (Muglia et al., 1997).”
BackgroundMethodInfluentialCorticotropin-releasing factor induces a place aversion independent of its neuroendocrine role
Cador, M., Ahmed, S. H., Koob, G. F., Le Moal, M., & Stinus, L. (1992) · Brain Research · doi:10.1016/0006-8993(92)91487-y · Cited by 74
Self-citationMouse models of altered CRH-binding protein expression
Seasholtz, A. F., Burrows, H. L., Karolyi, I. J., & Camper, S. A. (2001) · Peptides · doi:10.1016/s0196-9781(01)00387-4 · Cited by 65
Cited by
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
“Central administration of CRF mimics the behavioral response to activation and stress in rodents, and administration of competitive CRF receptor antagonists generally has anti-stress effects (for reviews, see Dunn and Berridge, 1990; Koob et al., 1994; Koob et al., 2001; Sarnyai et al., 2001).”
BackgroundSelf-citationThe neurobiology of addiction: a neuroadaptational view relevant for diagnosis
Koob, G. F. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01586.x · Cited by 397
Self-citationAddiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Self-citationCorticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation
Heinrichs, S. C., & Koob, G. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052092 · Cited by 353
“CRF receptors also have been knocked out in single and double mutant mice to explore the functional significance of CRF1 and CRF2 binding sites (Bale et al., 2000; Koob et al., 2001).”
BackgroundSelf-citationThe role of CRF and CRF-related peptides in the dark side of addiction
Koob, G. F. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.008 · Cited by 290
Self-citation
Metadata
- Authors
- Koob, G. F., Bartfai, T., & Roberts, A. J.
- Venue
- International Journal of Comparative Psychology
- Publisher
- California Digital Library (CDL)
- Published
- 2001
- Volume
- 14
- Issue
- 3
- ISSN
- 0889-3667 (ISSN-L)
- 2168-3344
- OpenAlex
- W295238378
- Cited by
- 9
- References
- 9
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.